A Comparative Study: Non-Surgical Spinal Decompression and Spinal Manipulative Therapy- Utilizing a Quantifiable Musculoskeletal Functional Assessment Risk Analysis Tool (MSDR®) in Patients With Chronic Low Back Pain

NCT ID: NCT00732394

Last Updated: 2008-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To administer the MSDR® (Musculoskeletal Disorder Reporting) instrument to document the musculoskeletal profile of patients with chronic low back pain, a prospective, non-randomized, multicenter treatment trial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MSDR

The MSDR® questionnaire establishes an individual's musculoskeletal functional status using information gathered from 1) a questionnaire the patient fills out regarding medical history, chronic medical conditions, and health risk factors; 2) anatomic pain survey completed by the patient; and 3) evaluation by a trained researcher of various patient biometric parameters related to range of motion. Stratifying an individual into a risk category with this evidence-based assessment tool then permits an assessment of which patients respond long term to therapy.

MSDR® demonstrates the ability to benchmark specific musculoskeletal findings (both clinical and sub-clinical) to ICD-9 Diagnoses supported by diagnostic, radiographic and/or MRI findings where clinically indicated.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Musculoskeletal Disorder Reporting Tool

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have Informed Consent Signed
* Lumbar Disc Herniations under 5mm without Sequestered Fragments
* Lumbar Disc Bulging
* Lumbar Degenerative Disc Disease (mild and moderate severity)
* Non-pregnant Females and Males suffering from Chronic Low Back Pain from 18 to 65 years of age
* Segmental Dysfunction Secondary to Dyskinesia
* Unresolved Nerve Entrapment Syndrome
* Patients must be able to comply with study protocol
* Joint Fixation Syndrome
* Premenopausal Female Patients, excluding patients who have undergone a hysterectomy, oophorectomy, or tubal ligation, must have one of the following methods of contraception and must have a negative serum or urine b-HCG pregnancy test performed within 48 hours before initiating protocol specified treatment.

Exclusion Criteria

* Contraindications to Spinal Manipulative Therapy
* Lumbar Canal Stenosis resulting in significant neurological comprimise
* Any Spinal Cord Compression resulting in significant neurological comprimise
* Cauda Equina Syndrome
* Infection
* Osteomyelitis

-\>65 years of age
* History of Back or Neck Surgery
* Acute Arthritis
* Signs or Symptoms of Arterial Aneurysm
* History of Active Cancer with Bone Metastasis
* Widespread Staphyloccal and/or Strepococcal Infection
* Acute Gout
* Serious unstable medical illness such as cardiovascular, renal, respiratory, endocrine, gastrointestinal, or psychiatric.
* Unstable Spondylosis, Spondylolisthesis, or Spondylolysis
* Prior adverse experience with Spinal Manipulation Therapy
* Uncontrolled Diabetic Neuropathy
* Gonorreal Spinal Arthritis
* Tuberculosis to the Bone
* Maligancy with Metatasis to Bone
* Excessive Spinal Osteoporosis
* Osteomalacia
* Ankylosis
* Syphlitic Articular or Peri-Articular Lesions
* Active Low Back Injury Resulting from a Motor Vehicle Accident or Work Related Injury
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MedAppraise, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Back2Life of Florida, Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric K Groteke, DC

Role: STUDY_CHAIR

MedAppraise, Inc.

Luis Crespo, MD

Role: PRINCIPAL_INVESTIGATOR

Crespo and Associates

Mark Scinico, MD

Role: STUDY_DIRECTOR

Concentra

Damon J Stafford, DC

Role: PRINCIPAL_INVESTIGATOR

Back2Life of Florida, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Back2Life of Florida, Inc.

Clearwater, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eric K Groteke, DC

Role: CONTACT

Phone: 727-797-0500

Email: [email protected]

Damon J Stafford, DC

Role: CONTACT

Phone: 727-797-0500

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tammy Cravotta

Role: primary

Matt Erickson, DC

Role: backup

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TCT06-002

Identifier Type: -

Identifier Source: org_study_id